Clinical Trial Update: Study of Cingal for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide at 39 Weeks Follow up [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing Cingal to Triamcinolone Hexacetonide for knee osteoarthritis, completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• Cingal
• Triamcinolone hexacetonide (triamcinolone hexacetonide)

Snippet

Sponsor: Anika Therapeutics, Inc. | Conditions: Knee Osteoarthritis | Phase 3 | Status: COMPLETED | Results posted: 2023-05-31